Overview

Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.

NDC labeler codes
0003
Strengths
Nivolumab 10 mg/mL; Nivolumab 120 mg/mL; Hyaluronidase (Human recombinant) 2000 U/mL; Trospium chloride 20 mg/1; Atazanavir sulfate 300 mg/1; Ipilimumab 5 mg/mL; Iberdomide hydrochloride .75 mg/1; Iberdomide hydrochloride 1 mg/1; Apixaban .15 mg/1; Apixaban .5 mg/1; Repotrectinib 160 mg/1; Xanomeline 50 mg/1; Xanomeline 125 mg/1; Trospium chloride 30 mg/1; Xanomeline 100 mg/1; Repotrectinib 40 mg/1; Deucravacitinib 6 mg/1; Nivolumab 12 mg/mL; Relatlimab 4 mg/mL; Triamcinolone acetonide 80 mg/mL
Dosage forms
Injection, Tablet, Capsule, Injection, Solution, Tablet, Film coated, Kit, Injection, Powder, Lyophilized, For solution, Capsule, Coated pellets, Injection, Suspension, Injection, Powder, For solution, Solution, Capsule, Gelatin coated, Tablet, For suspension, Powder
Routes
Oral, Intravenous, Subcutaneous, Intramuscular, Intra-articular, Intralesional, Topical
Drug classes (FDA established)
Kinase Inhibitor, Programmed Death Receptor-1 Blocking Antibody, Factor Xa Inhibitor, Corticosteroid, Protease Inhibitor, Selective T Cell Costimulation Modulator, Cholinergic Muscarinic Agonist, Cholinergic Muscarinic Antagonist, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Endoglycosidase, SLAMF7-directed Immunostimulatory Antibody, CTLA-4-directed Blocking Antibody, Monobactam Antibacterial, Tyrosine Kinase 2 Inhibitor, Lymphocyte Activation Gene-3 Blocker, Cytochrome P450 3A Inhibitor, Selective T Cell Costimulation Blocker
Package NDCs
73

NDC codes

Newest listings first. Each row links to the product’s NDC page.

E.R. Squibb & Sons, L.L.C. NDC Codes: finished products
ProductStrengthForm · routeProduct NDCPackage NDCs (11-digit)HCPCS
ZenbexusiberdomideIberdomide hydrochloride .75 mg/1CapsuleOral0003-570000003-5700-21—
ZenbexusiberdomideIberdomide hydrochloride 1 mg/1CapsuleOral0003-571000003-5710-21—
Eliquis SprinkleapixabanApixaban .15 mg/1CapsuleOral0003-089800003-0898-28—
EliquisapixabanApixaban .5 mg/1Tablet, For suspensionOral0003-102800003-1028-1200003-1028-2800003-1028-84—
Opdivo Qvantignivolumab and hyaluronidase-nvhyNivolumab 120 mg/mL; Hyaluronidase (Human recombinant) 2000 U/mLInjection, SolutionSubcutaneous0003-612000003-6120-01—
Opdivo Qvantignivolumab and hyaluronidase-nvhyNivolumab 120 mg/mL; Hyaluronidase (Human recombinant) 2000 U/mLInjection, SolutionSubcutaneous0003-312000003-3120-01—
AugtyrorepotrectinibRepotrectinib 160 mg/1CapsuleOral0003-416000003-4160-1400003-4160-60—
Cobenfyxanomeline and trospium chlorideXanomeline 50 mg/1; Trospium chloride 20 mg/1Capsule, Coated pelletsOral0003-005000003-0050-1400003-0050-6000003-0050-98—
Cobenfyxanomeline and trospium chlorideXanomeline 125 mg/1; Trospium chloride 30 mg/1Capsule, Coated pelletsOral0003-012500003-0125-1400003-0125-6000003-0125-98—
Cobenfyxanomeline and trospium chlorideXanomeline 100 mg/1; Trospium chloride 20 mg/1Capsule, Coated pelletsOral0003-110000003-1100-1400003-1100-6000003-1100-98—
Cobenfyxanomeline and trospium chloride—Kit0003-515000003-5150-14—
Cobenfyxanomeline and trospium chloride—Kit0003-520000003-5200-56—
AugtyrorepotrectinibRepotrectinib 40 mg/1CapsuleOral0003-404000003-4040-1200003-4040-60—
SotyktudeucravacitinibDeucravacitinib 6 mg/1Tablet, Film coatedOral0003-089500003-0895-1100003-0895-91—
Opdualagnivolumab and relatlimab-rmbwNivolumab 12 mg/mL; Relatlimab 4 mg/mLInjectionIntravenous0003-712500003-7125-11—
OpdivonivolumabNivolumab 10 mg/mLInjectionIntravenous0003-375600003-3756-14J9299
Kenalog-80triamcinolone acetonideTriamcinolone acetonide 80 mg/mLInjection, SuspensionIntra-articular, Intramuscular0003-031500003-0315-0500003-0315-20—
OpdivonivolumabNivolumab 10 mg/mLInjectionIntravenous0003-373400003-3734-13J9299
ELIQUIS 30-Day Starter Packapixaban—Kit0003-376400003-3764-74—
ELIQUIS 30-Day Starter Packapixaban—Kit0003-3765——
EmplicitielotuzumabElotuzumab 300 mg/1Injection, Powder, Lyophilized, For solutionIntravenous0003-229100003-2291-11—
EmplicitielotuzumabElotuzumab 400 mg/1Injection, Powder, Lyophilized, For solutionIntravenous0003-452200003-4522-11—
Evotazatazanavir and cobicistatAtazanavir sulfate 300 mg/1; Cobicistat 150 mg/1TabletOral0003-364100003-3641-11—
OpdivonivolumabNivolumab 10 mg/mLInjectionIntravenous0003-377200003-3772-11J9299
OpdivonivolumabNivolumab 10 mg/mLInjectionIntravenous0003-377400003-3774-12J9299
ReyatazatazanavirAtazanavir sulfate 50 mg/1PowderOral0003-363800003-3638-10—
EliquisapixabanApixaban 2.5 mg/1Tablet, Film coatedOral0003-089300003-0893-2100003-0893-3100003-0893-91—
EliquisapixabanApixaban 5 mg/1Tablet, Film coatedOral0003-089400003-0894-2100003-0894-3100003-0894-70+1 more—
OrenciaabataceptAbatacept 125 mg/mLInjection, SolutionSubcutaneous0003-218800003-2188-1100003-2188-5100003-2188-90+1 more—
OrenciaabataceptAbatacept 50 mg/.4mLInjection, SolutionSubcutaneous0003-281400003-2814-11—
OrenciaabataceptAbatacept 87.5 mg/.7mLInjection, SolutionSubcutaneous0003-281800003-2818-11—
NulojixbelataceptBelatacept 250 mg/1Injection, Powder, Lyophilized, For solutionIntravenous0003-037100003-0371-13—
YervoyipilimumabIpilimumab 5 mg/mLInjectionIntravenous0003-232700003-2327-11—
YervoyipilimumabIpilimumab 5 mg/mLInjectionIntravenous0003-232800003-2328-22—
SpryceldasatinibDasatinib 80 mg/1TabletOral0003-085500003-0855-22—
SpryceldasatinibDasatinib 140 mg/1TabletOral0003-085700003-0857-22—
AzactamaztreonamAztreonam 1 g/1Injection, Powder, For solutionIntramuscular, Intravenous0003-256000003-2560-16—
AzactamaztreonamAztreonam 2 g/1Injection, Powder, For solutionIntramuscular, Intravenous0003-257000003-2570-16—
Kenalog-40triamcinolone acetonideTriamcinolone acetonide 40 mg/mLInjection, SuspensionIntra-articular, Intramuscular0003-029300003-0293-0500003-0293-2000003-0293-28—
Kenalog-10triamcinolone acetonideTriamcinolone acetonide 10 mg/mLInjection, SuspensionIntra-articular, Intralesional0003-049400003-0494-20—
HaloghalcinonideHalcinonide 1 mg/mLSolutionTopical0003-024900003-0249-1500003-0249-20—
OrenciaabataceptAbatacept 250 mg/15mLInjection, Powder, Lyophilized, For solutionIntravenous0003-218700003-2187-13—
SpryceldasatinibDasatinib 100 mg/1TabletOral0003-085200003-0852-22—
SpryceldasatinibDasatinib 70 mg/1TabletOral0003-052400003-0524-11—
SpryceldasatinibDasatinib 20 mg/1TabletOral0003-052700003-0527-11—
SpryceldasatinibDasatinib 50 mg/1TabletOral0003-052800003-0528-11—
BaracludeentecavirEntecavir .5 mg/1Tablet, Film coatedOral0003-161100003-1611-12—
BaracludeentecavirEntecavir 1 mg/1Tablet, Film coatedOral0003-161200003-1612-12—
BaracludeentecavirEntecavir .05 mg/mLSolutionOral0003-161400003-1614-12—
ReyatazatazanavirAtazanavir sulfate 300 mg/1Capsule, Gelatin coatedOral0003-362200003-3622-12—

E.R. Squibb & Sons, L.L.C.: common questions

What is E.R. Squibb & Sons, L.L.C.'s NDC labeler code?
0003. The labeler code is the first segment of each NDC. About labeler codes.
Is there a J-code for E.R. Squibb & Sons, L.L.C.?
Med-Code's HCPCS directory matches J9299 to these products. NDC vs J-code.
Which NDC goes on a claim?
The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in